| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.032 | 0.8 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.037 | 0.8 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |